Summary
Background
The strongest evidence in medical clinical literature is represented by randomized controlled trials (RCTs). This study was designed to evaluate neurosurgically relevant RCTs published recently by neurosurgeons.
Method
A literature search in MEDLINE and EMBASE included all clinical studies published up to 30 June 2006. RCTs with neurosurgical relevance published by at least one author with affiliation to a neurosurgical department were selected. The number and characteristics of individual trials were recorded, and the quality of the trials with regard to study design, quality of reporting, and relevance for clinical practice was assessed by two different investigators using a modification of the Scottish Intercollegiate Guidelines Network methodology checklist. Changes of RCT quality over time as well as factors influencing the quality were analyzed.
Findings
From the initial search results (MEDLINE n = 3,860, EMBASE n = 3,113 articles), 159 RCTs published by neurosurgeons were extracted for final evaluation. Of the RCTs, 62% have been published since 1995; 52% came from the USA, UK, and Germany. The median RCT sample size was 78 patients and the median follow-up 35.7 weeks. Fifty-two percent of all RCTs were of good, 37% of moderate, and 11% of bad quality, with an improvement over time. RCTs with financial funding and RCTs with a sample size of >78 patients were of significantly better quality. There were no major differences in the rating of the studies between the two investigators.
Conclusions
Only a fraction of neurosurgically relevant literature consists of RCTs, but the quality is satisfying and has significantly improved over the last years. An adequate sample size and sufficient financial support seem to be of substantial importance with regard to the quality of the study. Our data also show that by using a standardized checklist, the quality of trials can be reliably assessed by observers of different experience and educational levels.
Similar content being viewed by others
References
Curry JI, Reeves B, Stringer MD (2003) Randomized controlled trials in pediatric surgery: could we do better? J Pediatr Surg 38:556–559. doi:10.1053/jpsu.2003.50121
Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ (1995) Users‘ guides to the medical literature IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA 274:1800–1804. doi:10.1001/jama.274.22.1800
Haines SJ (1979) Randomized clinical trials in the evaluation of surgical innovation. J Neurosurg 51:5–11
Haines SJ (1983) Randomized clinical trials in neurosurgery. Neurosurgery 12:259–264. doi:10.1097/00006123-198303000-00001
Haines SJ (2001) History of randomized clinical trials in neurosurgery. Neurosurg Clin N Am 12:211–216
Hill CL, LaValley MP, Felson DT (2002) Secular changes in the quality of published randomized clinical trials in rheumatology. Arthritis Rheum 46:779–784. doi:10.1002/art.512
Johnson AG, Dixon JM (1997) Removing bias in surgical trials. BMJ 314:916–917
Kyriakidi M, Ioannidis JP (2002) Design and quality considerations for randomized controlled trials in systemic sclerosis. Arthritis Rheum 47:73–81. doi:10.1002/art1.10218
Majeed AW, Troy G, Nicholl JP, Smythe A, Reed MW, Stoddard CJ, Peacock J, Johnson AG (1996) Randomised, prospective, single-blind comparison of laparoscopic versus small-incision cholecystectomy. Lancet 347:989–994. doi:10.1016/S0140-6736(96) 90143-9
Morris GF, Bullock R, Marshall SB, Marmarou A, Maas A, Marshall LF (1999) Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: Results of two phase III clinical trials. J Neurosurg 91:737–743
Ostertag CB (2001) Measuring the importance of scientific results in neurosurgery. Acta Neurochir Suppl (Wien) 78:185–188
Penn RD, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B, Kroin JS (1989) Intrathecal baclofen for severe spinal spasticity. N Engl J Med 320:1517–1521
Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, Sheppard D, Twombley J, French PP, Herwaldt LA, Bentler S, Brown K, Bushnell W, Coffman S, Finlay J, Forbes R, Hintemiester M, James C, Helgerson B, Preston A, Swift J (2002) Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 346:1871–1877. doi:10.1056/NEJMoa003069
Richter HP, Kast E, Tomczak R, Besenfelder W, Gaus W (2001) Results of applying ADCON-L gel after lumbar discectomy: the German ADCON-L study. J Neurosurg 95:179–189
Scottish Intercollegiate Guidelines Network (SIGN) SIGN 50 (2005) A guideline developers' handbook. Methodology Checklist 2: Randomised Controlled Trials www.sign.ac.uk
Solomon MJ, Laxamana A, Devore L, McLeod RS (1994) Randomized controlled trials in surgery. Surgery 115:707–712
Solomon MJ, McLeod RS (1995) Should we be performing more randomized controlled trials evaluating surgical operations? Surgery 118:459–467. doi:10.1016/S0039-6060(05) 80359-9
Solomon MJ, McLeod RS (1998) Surgery and the randomised controlled trial: past, present and future. Med J Aust 169:380–383
Thomas DG, Kitchen ND (1994) Minimally invasive surgery. Neurosurgery. BMJ 308:126–128
Troidl H (1998) Conceptional and structural conditions for successful clinical research. Langenbecks Arch Surg 383:306–316. doi:10.1007/s004230050138
Uhl W, Wente MN, Buchler MW (2000) Surgical clinical studies and their practical realization. Chirurg 71:615–625. doi:10.1007/s001040051113
Vranos G, Tatsioni A, Polyzoidis K, Ioannidis JP (2004) Randomized trials of neurosurgical interventions: a systematic appraisal. Neurosurgery 55:18–25. doi:10.1227/01.NEU.0000126873.00845.A7
Winkler JT (1987) The academic celebrity sndrome. Lancet 21:450. doi:10.1016/S0140-6736(87) 90151-6
Wyler AR, Hermann BP, Somes G (1995) Extent of medial temporal resection on outcome from anterior temporal lobectomy: a randomized prospective study. Neurosurgery 37:982–990
Author information
Authors and Affiliations
Corresponding author
Additional information
Comments
Every single neurosurgeon should read and study the randomized trials herself/himself and he/she should evaluate the value individually. One should be aware that not every trial gives level I evidence, and all are not drawn according to trial guidelines.
V. Benes
Prague, Czech Republic
The actual results reflect the state of RCTs during the EBM hype. The total number of RCTs is very small, actually too small to have a substantial impact on the developments in our field. The current situation is even less promising for RCTs because the premise of equipoise for studying neurosurgcal issues does not work anymore. The current distribution of information and the propagation of guidelines leave no database anymore for surgical trials under the equipoise premise. Only emerging new techniques can be compared with traditional ones under these preconditions.
H-J. Steiger
Dusseldorf, Germany
Rights and permissions
About this article
Cite this article
Schöller, K., Licht, S., Tonn, JC. et al. Randomized controlled trials in neurosurgery—how good are we?. Acta Neurochir 151, 519–527 (2009). https://doi.org/10.1007/s00701-009-0280-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-009-0280-y